CatalYms Visugromab Phase 12a Data Demonstrating Clinical Proof-of-Concept for Reversing Resistance to Checkpoint Inhibitors through GDF-15 Neutralization Published in Nature
| HRSAX Fund | USD 16.73 0.70 4.02% |
Slightly above 61% of Rational Real's investor base is looking to short. The analysis of overall sentiment of trading Rational Real Strategies mutual fund suggests that many investors are alarmed at this time. Rational Real's investing sentiment can be driven by a variety of factors including economic data, Rational Real's earnings reports, geopolitical events, and overall market trends.
Rational |
MUNICH, December 11, 2024--Clinical proof of concept for CatalYms lead drug candidate visugromab for reversing resistance through GDF-15 neutralization were published in Nature
Read at finance.yahoo.com
 |
Rational Real Fundamental Analysis
We analyze Rational Real's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rational Real using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rational Real based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
One Year Return
One Year Return Comparative Analysis
Rational Real is currently under evaluation in one year return among similar funds. One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
Rational Real Strategies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rational Real mutual fund to make a market-neutral strategy. Peer analysis of Rational Real could also be used in its relative valuation, which is a method of valuing Rational Real by comparing valuation metrics with similar companies.
Peers
Rational Real Related Equities
| RHSAX | Rational Strategic | 1.05 | ||||
| RDMCX | Rational Dynamic | 0.34 | ||||
| RDMIX | Rational Dynamic | 0.32 | ||||
| RDMAX | Rational Dynamic | 0.32 | ||||
| RFXIX | Rational Special | 0.06 | ||||
| RFXAX | Rational Special | 0.06 | ||||
| RFXCX | Rational Special | 0.06 | ||||
| HRSFX | Rational Real | 3.36 |
Other Information on Investing in Rational Mutual Fund
Rational Real financial ratios help investors to determine whether Rational Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rational with respect to the benefits of owning Rational Real security.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |